INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE)

CUSIP: 46137V787

Q2 2018 13F Holders as of 30 Jun 2018

Share change
+918,507
SEC-reported price per share
$54.71
Number of holders
69
Value change
+$50,325,083
Number of buys
68

Security key

46137V787

Report period

Q2 2018

Institutions

69

Top holders

10

Ownership snapshot

Top reported holders of PBE - INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Disclosed value leader
Comparable rows
0/0
Latest evidence
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q2 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
69
Shares
938,078
Rows available
69
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2018 vs Q2 2016 Across Filers

Q2 2016 holders
0
Q2 2018 holders
69
Holder diff
69
Investor Q2 2016 Shares Q2 2018 Shares Share Diff Share Chg % Q2 2016 value Q2 2018 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .